ClaraScience logoClaraScienceResearch-Grade Peptides
Research Reference

How to Read HPLC Result-versus-Specification Columns in Laboratory Peptide Documentation

Laboratory peptide documentation is the peptide COA, chromatogram and peak-table package that shows how to read HPLC results for a research peptide lot in Australia. This article is a field-by-field protocol for peptide COA documentation: a reading order for the specification-versus-result table, the chromatogram, the peak table, and the lot-header identifiers that must concord before any purity figure is filed. Identity fields are checked first so that a purity number is never assigned to the wrong lot. Method identifiers and detection wavelength are checked second so that area-percent figures are not compared across incompatible methods. Specification limits are then compared with reported results, after which the chromatogram and peak table confirm that headline purity is the main-peak area per cent after documented exclusions. Advice on how to read experimental material stresses inspecting methods and tabulated data together rather than isolated summaries. The scope is analytical chemistry, identity, purity reporting and laboratory practice for research-use lots from Australian stock with tracked dispatch and batch documentation.

What should laboratory peptide documentation show in the HPLC result-versus-specification table?

The HPLC block on a certificate of analysis is usually a table, not a paragraph. Typical columns are Test (or Method), Specification (or Limit), Result, and sometimes Disposition. Those four columns answer four different questions and must not be collapsed into a single headline percentage. The Test column should name the measurement, not merely "purity". A usable entry states the technique and the reporting basis, for example "Purity by RP-HPLC, area normalisation, 220 nm" or "Identity by HPLC retention time versus reference". If the test name omits wavelength, calculation basis or chromatographic mode, the result cannot be compared with another lot. Related-substances tests are distinct from main-peak purity tests even when both use HPLC; they often use different sample loads, run times or integration events. The Specification column is the pre-set acceptance criterion: an operator, a number and a unit (not less than a stated area per cent; retention time within a stated window; unspecified impurity and total related substances not more than stated area per cent). A specification without an operator, or an "HPLC purity" limit without wavelength, is incomplete. The Result column is the value obtained for the named lot and must use the same unit as the specification. A result of 99.2 per cent area at 220 nm does not meet a specification written at 214 nm until method equivalence is documented. Results should be numeric wherever the specification is numeric. The Disposition column, where present, is a coded judgement (complies / does not comply). It is not a substitute for the result. Guidance titled "13. How to read a journal article" treats methods and results as separate objects of inspection rather than a single verdict; the same separation belongs on a certificate. Confirm test name, operator, numeric result and arithmetic comparison before reading disposition.

How should the HPLC chromatogram and peak table be reconciled with the COA purity result?

A certificate that reports HPLC purity without a chromatogram and a peak table reports a conclusion without its data. The chromatogram is the primary experimental record; the peak table is the quantified reading of that record; the COA purity line is a transcription of one cell of that table. All three must agree. Read the chromatogram axes first. The x-axis is time in minutes; the y-axis is detector response, commonly milli-absorbance units. Note whether the main peak is on-scale. A truncated apex or an axis that starts above the baseline makes area integration untrustworthy as a purity basis. Peak labels, printed retention times and integration start/stop marks should be visible. If they are absent, the image is illustrative rather than a record. Then read the peak table: peak name or relative retention time, retention time, area, area per cent, height and, where reported, tailing factor, plate count and resolution to the adjacent peak. The main-peak area per cent should equal the COA "purity by HPLC" result to the reported decimal place. If the COA states 99.41 per cent and the table's main peak is 97.2 per cent, the certificate is internally inconsistent. After documented exclusions (solvent, system peaks, peaks below the reporting threshold), included area per cents should total 100.0 per cent within rounding. A table that reaches 100 per cent only because solvent was included is not a peptide purity result. Count integrated peaks against peaks visible above the stated reporting threshold. Sample identification on the chromatogram must match the COA header. "Suggestions on how to read experimental material in information science" stresses inspecting methods and tabulated data together rather than isolated summaries; the chromatogram-to-table-to-certificate check is that inspection for HPLC.

Which lot, method and wavelength fields must match before an HPLC number is filed?

An HPLC purity percentage cannot be filed if it is not tied to a physical vial, a method and a detection channel. Read laboratory peptide documentation as a concordance problem before reading it as a chemistry problem. Lot concordance is three-way. The lot or batch number on the vial label, the lot number in the COA header, and the sample identifier on the chromatogram or sequence table must be identical, including suffix letters that distinguish sub-lots. Catalogue codes and product names should match the sequence or trivial name ordered. A COA for a similarly named analogue is not a COA for the lot received. Method concordance is the next gate. Record the method identifier and revision, column description (bonded phase, length, internal diameter, particle size), gradient programme or isocratic composition, flow, column temperature, sample load volume, diluent, and detection wavelength plus bandwidth. Area per cent at 220 nm is not interchangeable with 214 nm or 280 nm. Peptides without a strong aromatic chromophore may be reported only at low UV; the COA should state that channel. If purity and related substances are separate runs, each needs its own method identity. Date fields are documentation timestamps: date of manufacture or synthesis, date of analysis, date of approval, and any stated retest date as a documentation horizon. Analysis date should not precede manufacture date. Sign-off fields (analyst, reviewer, signature, page count) show that the report was authorised as a complete document; a missing chromatogram page is a missing record. "Documentation about Atlas of Living Australia tools: how to find information" emphasises locating each information element before interpreting it. Locate lot, method, wavelength and sample ID before interpreting area per cent. Approaching the certificate with the wrong question—taking a percentage as self-identifying—is a form of misreading.

How do complies, not detected and reporting-threshold footnotes differ from HPLC area-percent purity?

Area-percent purity is a calculation. Disposition codes are judgements. Reporting-threshold footnotes define which peaks enter the calculation. Treating these as synonyms is a reading error. Area-percent purity (area normalisation) is the main-peak area divided by the sum of included peak areas, expressed as a percentage at a stated wavelength. It is not a mass-balance assay, not a net peptide content, and not a counter-ion corrected content. Those tests, when present, occupy different rows. "Complies" means the issuing laboratory compared a result with a specification and recorded a pass. Without the underlying number, a later reader cannot trend lots or check arithmetic. Where the specification is numeric, the result should be numeric. Disposition may accompany the number; it should not replace it. "Not detected" is not zero. It means no peak was observed above the detection capability as applied in that run. A value reported as less than the reporting threshold means a response was at or below the cut-off used for inclusion in normalisation. Reporting 0.00 per cent is ambiguous unless the COA states whether that figure is a rounded value below the threshold or a true absence. The footnote that states the reporting threshold is part of the result. Named related substances are often listed at relative retention times versus the main peak. Read the relative retention time, the peak name and the individual limit. Total related substances may be constructed as 100 per cent minus main-peak area per cent, or as the sum of included impurity areas; confirm which construction was used. "HOW TO BE READ PIAAC RESULTS FOR ADAPTATION TO NEW AGE?" is a reminder that numeric result tables are misread when a headline index is taken as the full record. Read the inclusion footnote, then the number, then the disposition.

What HPLC COA package should an Australian laboratory request before ordering a research lot?

Before a laboratory places an order, the supplier's documentation pack should be evaluated as a completeness test. For research peptides held in Australian stock, the minimum HPLC package is a lot-specific certificate of analysis, a chromatogram that is a chromatography-data-system export rather than a cropped screenshot, a peak table, method conditions sufficient to identify the run, and lot identifiers that can be matched to vial labels on arrival. Ask whether the COA is for the lot that will be dispatched, not for a historic example lot. Local stock makes that check possible at the time of ordering because the lot number is already assigned. Tracked dispatch then provides a shipment identifier that the receiving laboratory can file beside the COA lot number, so that containers and the analytical record remain linked. For multi-vial orders from one lot, a single COA is appropriate only if every vial carries that lot number; mixed lots require one COA per lot. Request the calculation basis on the certificate: wavelength, area-normalisation rules, exclusions, reporting threshold, and whether purity and related substances were separate runs. If mass-spectrometric identity is listed on the same COA, treat it as an orthogonal identity row, not as confirmation of the HPLC area per cent. Treat as incomplete: certificates with purity and no chromatogram; chromatograms with no sample ID; peak tables that do not sum; specifications without operators; results that say only "complies" against a numeric HPLC limit; and method fields that omit wavelength. Supplier evaluation for research materials is documentation evaluation. "Review: The Business of Books: How International Conglomerates Took over Publishing and Changed the Way We Read" concerns how presentation changes reading; the laboratory's defence is a fixed checklist applied to every lot, independent of layout. Australian stock, tracked dispatch and batch documentation are the operational counterparts of that checklist.

How (not) to read HPLC results on peptide COA documentation in Australia

The most frequent error is to copy the largest percentage on the page and stop. That number may be height per cent, may include solvent, may be an assay by a different method, or may belong to another lot's example chromatogram. "How (Not) To Read Heidegger" is, in its own field, a warning against approaching a text with the wrong question. The wrong question here is "what is the purity?". The right questions are which test, at which wavelength, on which lot, with which peaks included, against which specification. Do not treat HPLC retention-time identity as sequence confirmation. Retention-time identity shows that a peak eluted in a window; it does not assign amino-acid sequence. If the COA also reports mass-to-charge or monoisotopic mass, that is a separate identity test on its own row. Do not compare lots across unnamed methods. A 99.5 per cent area result from a short gradient at 220 nm is not comparable with a 98.8 per cent result from a high-resolution related-substances method at 214 nm. Without method identity, trending is invalid. Do not ignore integration events. Skimmed peaks, dropped baselines through a hump, and negative dips after the main peak alter area per cent. If integration events are not shown, the peak table cannot be audited. Do not file a related-substances chromatogram as the purity chromatogram: long run times and high sample loads are typical of impurity methods. Do not accept a certificate whose chromatogram header disagrees with the COA header. Close reading of a primary text means reading the words that are there. The chromatogram is the primary text; the COA summary is secondary. Keep the protocol on file: header concordance, method and wavelength, specification versus result, chromatogram versus peak table, footnotes, disposition last.

Apply this checklist to documented stock

You now have a practical way to read purity figures, method notes, and lot traceability. When you source materials, hold suppliers to that same checklist — ClaraScience issues batch documentation with every order and dispatches from Australian warehouses with Express tracked shipping.

Start with a retail order to review documentation end-to-end, or register for wholesale if you restock multiple compounds.

Frequently asked questions

What is the first check when reading HPLC results on laboratory peptide documentation?

Confirm three-way lot concordance first: vial label, COA header and chromatogram sample identifier must match character for character. Then read the test name, detection wavelength and specification operator before copying any purity percentage. A figure that cannot be tied to a named lot and a named HPLC method is not yet a laboratory record. File the chromatogram and peak table with the certificate.

Why might the COA HPLC purity differ from the peak-table main-peak area per cent?

Common causes are transcription rounding, inclusion or exclusion of solvent or system peaks, a different wavelength channel, a related-substances run filed against a purity row, or a chromatogram belonging to another lot. Reconcile y-axis scale, peak labels, area-percent sum after documented exclusions, and sample ID before accepting either figure. Internal inconsistency means the HPLC result is not yet usable.

Does a disposition of complies replace a numeric HPLC result?

No. Disposition is a pass or fail judgement against a specification. Where the limit is numeric, the result should be numeric so the laboratory can audit arithmetic and trend lots. A certificate that states only complies against an HPLC purity limit, without a percentage, a chromatogram and a peak table, is incomplete research documentation.

Is HPLC area-percent purity the same as net peptide content?

No. Area-percent purity is a relative peak-area calculation at a stated wavelength after stated exclusions. Net peptide content and counter-ion determinations are separate tests and occupy separate certificate rows. Do not substitute an HPLC area-percent figure for a content result when filing research records, and do not compare the two as if they shared a unit.

What HPLC documents should accompany Australian local stock and tracked dispatch?

Request a lot-specific certificate, chromatogram, peak table and method identifiers for the lot number that will be dispatched from Australian stock. File the tracked-dispatch identifier against that lot on receipt. Multi-vial orders from one lot share one certificate; mixed lots require one certificate per lot. Reject example chromatograms that do not name the dispatched lot.

Can HPLC retention time on a peptide COA confirm sequence?

No. Retention-time identity only shows elution within a specified window versus a reference. Sequence-level identity, when listed, is a separate mass-spectrometric or equivalent row. Read that row independently from HPLC area-percent purity, and do not treat a matching retention time as a substitute for a mass or sequence record.

References

  1. DOI:10.5694/j.1326-5377.1992.tb137249.x — 13. How to read a journal article — Medical Journal of Australia — 1992
  2. DOI:10.1002/asi.5090180408 — Suggestions on how to read experimental material in information science — American Documentation — 1967
  3. DOI:10.3897/tdwgproceedings.1.19941 — Documentation about Atlas of Living Australia tools: how to find information — Proceedings of TDWG — 2017
  4. DOI:10.7816/ulakbilge-05-15-06 — HOW TO BE READ PIAAC RESULTS FOR ADAPTATION TO NEW AGE? — Ulakbilge Dergisi — 2017
  5. DOI:10.1177/1329878x0210300127 — Review: The Business of Books: How International Conglomerates Took over Publishing and Changed the Way We Read — Media International Australia — 2002
  6. DOI:10.5840/acpq199569241 — How (Not) To Read Heidegger — American Catholic Philosophical Quarterly — 1995

Research use only

This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.